Skip to main content

Table 1 Schedule of participant enrolment, interventions, and assessment in the trial

From: Placental growth fActor Repeat sampling for Reduction of adverse perinatal Outcomes in women with suspecTed pre-eclampsia: study protocol for a randomised controlled trial (PARROT-2)

 

Screeninga

Trial entry

Trial period

At hospital discharge to home

Confirmation of eligibility

âś“

   

Consent

 

âś“

  

Demographic/clinical data collection

 

âś“

  

Subsequent blood sample(s) for PlGF-based test (revealed or concealed as per randomised allocation)

  

âś“

 

SAEs

  

âś“

âś“

Post-delivery outcome data collection

   

âś“

  1. aScreening to be recorded of all women considered possibly eligible for the study